1 hr ago
GlaxoSmithKline Finally Received Approval from FDA for Its Diabetes Drug Tanzeum
GlaxoSmithKline , the renowned research-based pharmaceutical and healthcare firm, has finally received the green signal in the US for marketing its once-weekly diabetes drug Tanzeum which the company expects to launch in third quarter 2014.
Trending on the Topix Network
Fri Apr 18, 2014
AbbVie urges U.S. court to avoid gay rights issue in HIV drug case
An Abbott Laboratories spinoff urged a federal appeals court to revisit a ruling in a case against GlaxoSmithKline Plc, but without disturbing landmark constitutional protections for gays and lesbians.
Lincoln Daily News
China's new breed of whistleblowers takes on big business
Chinese lawyer Hao Junbo wants to make you rich if you're a whistleblower after a bounty.
Austria adult mouth care market: GlaxoSmithKline the leading player with 31% value share
GlaxoSmithKline Pharma led the Austria adult mouth care market in 2012, holding a 31% value share, generated with its well-known brands Chlorhexamed and Corsodyl Zahnfleisch Fluid.
Thu Apr 17, 2014
GlaxoSmithKline Announces Approval In Canada For Incruse...
GlaxoSmithKline plc today announced that Incrusea Elliptaa has received market authorisation in Canada for the long-term once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease , including chronic bronchitis and emphysema.
GSK and Genmab receive FDA approval for ArzerraA (ofatumumab) as...
"Today's approval by the FDA for the use of Arzerra in the first-line setting means that appropriate patients with CLL have a new treatment option."
Pharmaceutical Stocks For Income, Value, And Growth Investors
Health care is the largest component of the American economy, about one-sixth the gross domestic product.
Broker tips: Imperial Tobacco, Legal & General, GlaxoSmithKline...
Goldman Sachs has removed Imperial Tobacco from its 'Conviction List', saying it sees less potential upside from current levels.
Wed Apr 16, 2014
GSK says investigating claims of bribery in Jordan, Lebanon
In this 2013 file photo, a no entry sign is pictured outside the GlaxoSmithKline building in Hounslow, west London REUTERS/Luke MacGregor LONDON, April 16 - GlaxoSmithKline GSK.L, Britain's biggest drugmaker, said on Wednesday it was investigating allegations of bribery involving some of its staff in Jordan and Lebanon, following earlier claims of ... (more)
The Miami Herald
GlaxoSmithKline discloses new bribery inquiries
The company said Wednesday that it started looking into the conduct of "a small number of individuals" in December.
Wall Street Journal
Glaxo Examines Bribery Claims in Jordan, Lebanon
GlaxoSmithKline PLC is investigating claims its employees bribed doctors in Jordan and Lebanon by offering perks such as flexible travel arrangements and free samples that doctors could sell on, according to emails reviewed by The Wall Street Journal.
Tue Apr 15, 2014
GlaxoSmithKline executive buys Lakewood Ranch home
A pharmaceutical executive from GlaxoSmithKline has purchased a Lakewood Ranch Golf and Country Club Village home, adding to a list of national executives in Manatee.
Will The FDA's Approval Of Type 2 Diabetes Drug Tanzeum Help GlaxoSmithKline (GSK) Stock?
"Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adts with type 2 diabetes mellitus," it added.
Warsaw Business Journal
BBC: GlaxoSmithKline bribed Polish doctors
According to the BBC, British pharmaceutical giant GlaxoSmithKline' regional manager paid Polish doctors to promote the company's asthma drug Seretide.
Tuesday tips round-up: RWS Holdings, GlaxoSmithKline
As Chinese companies increasingly look to rigorously protect their intellectual property claims in the western world companies such as RWS Holdings will benefit.
Mon Apr 14, 2014
Drug firms have used dangerous tactics to drive sales to treat kids
Whistle-blower. Greg Thorpe, a former sales representative for GlaxoSmithKline, sits at a desk in Florida with papers from the case in which he alleged the company encouraged doctors to prescribe antidepressants to children when the FDA had not approved the drugs for pediatric use.
GlaxoSmithKline plc Given Hold Rating at Jefferies Group
's stock had its "hold" rating reiterated by equities research analysts at Jefferies Group in a research note issued to investors on Monday, Analyst Ratings Network.com reports.
Sun Apr 13, 2014
Drugs giant GlaxoSmithKline bribed doctors to boost sales, says whistleblower
Note: We do not store your email address but your IP address will be logged to prevent abuse of this feature.
Fri Apr 11, 2014